Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes by Coleman, R

Solid state physics / by 180965 Coleman, R. V.

Are measures of adiposity associated independently with incident cardiovascular disease in individuals with newly diagnosed type 2 diabetes? by Coleman, R, Holman, R

Algorithms for assessing cardiovascular risk in women. by Stevens, R, Coleman, R

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83). by Davis, T, Coleman, R, Holman, R

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83) by Davis, T, Coleman, R, Holman, R

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79. by Davis, T, Coleman, R, Holman, R

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation by Coleman, R, Stevens, R, Holman, R

Framingham risk equations underestimate coronary heart disease risk in diabetes. by Stevens, R, Coleman, R, Holman, R

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data by Coleman, R, Stevens, R, Holman, R

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine by Coleman, R, Stevens, R, Holman, R

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation by Coleman, R, Stevens, R, Holman, R

Predicting 6-year mortality risk in patients with type 2 diabetes: response to Wells et al. by Paul, S, Coleman, R, Price, H, Farmer, A

Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes: Response to Wells et al. by Paul, S, Coleman, R, Price, H, Farmer, A

Doing more with less; are there some ‘easy wins’ in the management of early breast cancer? by Dodwell, D, Richmond, A, Hazell, S, Coleman, R

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in Type 2 diabetes by Coleman, R, Stevens, R, Retnakaran, R, Holman, R

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. by Coleman, R, Stevens, R, Retnakaran, R, Holman, R

Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes. by Price, H, Coleman, R, Stevens, R, Holman, R

Could non-HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine? by Stevens, R, Coleman, R, Shine, B, Holman, R

A cardiovascular risk calculator for type 2 diabetes by Coleman, R, Stevens, R, Matthews, D, Holman, R